Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutathione synthesis and redox buffering system is a fundamental cellular network dedicated to maintaining redox homeostasis and neutralizing reactive oxygen species (ROS). It centers on the tripeptide glutathione (GSH), which is synthesized in two ATP-dependent steps by glutamate-cysteine ligase (GCL) and glutathione synthetase (GSS) [Lu, 2013]. The system maintains GSH in its reduced form through the action of glutathione reductase (GSR), which uses NADPH to convert oxidized glutathione (GSSG) back to GSH [Forman et al., 2009]. This pathway plays a dual role in human health: it protects normal cells from DNA damage and toxic insults, but it is frequently hijacked by cancer cells to confer resistance to oxidative stress and chemotherapeutic agents [Traverso et al., 2013]. Pharmacological intervention typically targets this system by either providing precursors like N-acetylcysteine to boost antioxidant capacity in respiratory or toxicological conditions, or by using inhibitors like buthionine sulfoximine to deplete GSH and sensitize malignant cells to therapy [Rushworth & MacEwan, 2008; Griffith, 1982]. Beyond synthesis, the system involves transporters like the cystine/glutamate antiporter (System Xc-) which provides the rate-limiting precursor cysteine [Dixon et al., 2012]. Dysregulation of this system is a hallmark of various pathologies, including neurodegenerative diseases where GSH depletion leads to neuronal death [Forman et al., 2009]. Monitoring the GSH/GSSG ratio serves as a primary biomarker for assessing the oxidative status of this system in clinical and research settings [Forman et al., 2009].
Modulation of intracellular glutathione levels through precursor supplementation, inhibition of rate-limiting enzymes like glutamate-cysteine ligase, or blockade of precursor transport systems [Rushworth & MacEwan, 2008; Griffith, 1982; Dixon et al., 2012].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione synthesis and redox buffering system (GSH system) (GSH system).